SPC Financial Inc. Has $476,000 Stock Holdings in The Clorox Company (NYSE:CLX)

SPC Financial Inc. boosted its holdings in shares of The Clorox Company (NYSE:CLX) by 2.2% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,485 shares of the company’s stock after buying an additional 75 shares during the period. SPC Financial Inc.’s holdings in Clorox were worth $476,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently bought and sold shares of the business. GoalVest Advisory LLC acquired a new position in shares of Clorox in the 1st quarter valued at about $31,000. First Foundation Advisors acquired a new position in Clorox in the 1st quarter valued at approximately $31,000. Core Wealth Advisors Inc. acquired a new position in Clorox in the 4th quarter valued at approximately $29,000. Innealta Capital LLC purchased a new stake in Clorox in the 2nd quarter worth approximately $30,000. Finally, Trifecta Capital Advisors LLC boosted its stake in shares of Clorox by 139.8% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after buying an additional 130 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Trading Up 1.5 %

Shares of NYSE:CLX opened at $165.32 on Wednesday. The Clorox Company has a 52-week low of $114.68 and a 52-week high of $169.09. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The company has a market cap of $20.53 billion, a P/E ratio of 85.66, a P/E/G ratio of 3.31 and a beta of 0.40. The stock’s 50-day moving average is $153.17 and its 200-day moving average is $144.15.

Clorox (NYSE:CLX) last issued its quarterly earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, topping the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The company had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.97 billion. Equities research analysts predict that The Clorox Company will post 6.63 earnings per share for the current year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 2.95%. The ex-dividend date is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

Insiders Place Their Bets

In other news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.51% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CLX. Deutsche Bank Aktiengesellschaft upped their price target on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research note on Friday, August 2nd. TD Cowen began coverage on Clorox in a research note on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price target for the company. BNP Paribas raised Clorox to a “strong sell” rating in a research note on Friday, September 6th. Barclays raised their price objective on shares of Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research report on Monday, August 5th. Finally, DA Davidson reissued a “neutral” rating and issued a $153.00 target price on shares of Clorox in a research report on Friday, September 6th. Six investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $146.13.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.